Ensera Launches Alliance Network to Tackle Challenges in Pharmaceutical Commercialization
Ensera Launches an Innovative Alliance Network
In an exciting development for the pharmaceutical and medical device industries, Ensera, a global Contract Development and Manufacturing Organization (CDMO), has launched the Ensera Alliance Network. This initiative seeks to tackle the complexities involved in the commercialization of combined drug-device products by uniting leading companies specializing in medical device platforms and filling services. The network incorporates notable partners such as SHL Medical, Stevanato Group, Ypsomed, Argonaut Manufacturing Services, and American Injectables.
Streamlined Commercialization for Drug-Device Products
The commercialization process for combined products often involves navigating through multiple suppliers, each contributing expertise in distinct areas such as medical device platforms, filling, final assembly, and packaging. This multi-supplier model can lead to increased complexity, potential delays, and misalignment in responsibilities and timelines. With the formation of the Ensera Alliance Network, Ensera aims to mitigate these challenges by fostering stronger connections between key supply chain elements.
"Too many combined product programs are held up by suppliers who fail to communicate effectively and by complex transfer of responsibilities," says Bobby O’Connor, Ensera’s Chief Commercial Officer. By assembling a trusted network of specialists under a more coordinated and responsive model, the Ensera Alliance Network enhances clients' efforts to streamline commercialization processes, minimize risks, and expedite market entry.
A Collaborative Approach to Overcome Challenges
The network is built on strong relationships, shared experience, and a granular understanding of how each organization operates. Darren Hieber, Ensera’s Vice President of Strategic Partnerships, elaborates on the initiative's collaborative nature. “By bringing our partners together from various fields—medical device platforms, filling, final assembly, and packaging—we can work more closely to address the specific needs of each program, identify challenges earlier, and assist our clients in navigating the transition to market.”
Expanding Network to Meet Evolving Needs
Ensera intends to gradually expand its network by incorporating organizations that complement the existing expertise, standards, and approaches of its current members. Importantly, membership in the Ensera Alliance Network is not exclusive. Clients retain the flexibility to engage directly with any of the network participants, maintaining independence while benefiting from collaborative opportunities.
About Ensera
Ensera stands out as an internationally recognized CDMO that supports pharmaceutical and medical device companies in designing, manufacturing, final assembly, labeling, and secondary packaging of injectable products, including autoinjectors and prefilled syringes. With flexible production sites compliant with Good Manufacturing Practices (GMP) across Europe, the US, and Asia, Ensera is uniquely equipped to manage small to medium batch sizes and integrate quality systems with cold chain infrastructure. As an approved partner for the assembly of market-leading injector platforms, Ensera combines expertise in medical devices and pharmaceuticals to ensure effective and compliant supply for combined products.
For more information regarding the Ensera Alliance Network, please visit Ensera Alliance Network.
Members of the Ensera Alliance Network:
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.